Together we fight till you win
Managing the multiple facets of Musculoskeletal Oncology
Together we fight till you win
As an emerging specialty of orthopaedic oncology, Musculoskeletal oncology involves bone and soft tissue disorders. Although rare, these cancers can develop in any part of the body that involves a bone including in the hands, arms, elbows, shoulders, scapula, feet, knees, thighs, hips, pelvis, or the sacrum. At American Oncology Institute our specialized team of experts adopt multidisciplinary approach and treat Musculoskeletal cancer with the help of evolved technology and techniques.
The qualified team at American Oncology Institute, focuses on the treatment of both cancerous and non-cancerous bone and soft tissue tumours, in addition to providing comprehensive care for genetic and acquired bone cancers.
Whether the Musculoskeletal disorder is straight forward or multifaceted, our integrated experts of surgical, medical and radiation oncologist's work together to understand the patient's unique diagnosis requirement and formulates an effective treatment plan.
A multi-disciplinary team of Medical, Radiation and Surgical Oncologists assess the patient's condition to arrive at the right treatment decision and personalize the treatment plan.
AOI practices evidence-based medicine to ensure precise outcomes. At AOI, each treatment is planned based on international protocols that are administered through decision support tools enabled by technology.
AOI's experienced cancer specialists create the most effective treatment plan following US University-level guidelines. The radiation treatment planning is done by a central team under the guidance of US-based experts that have decades of experience.
AOI conducts a weekly International Tumor Board wherein, the clinicians from US join their counterparts in India to jointly review complex cases. This multidisciplinary team jointly decides on diagnosis and treatment pathways based on US university level protocols.
While it is hard to ascertain the exact risk factors of musculoskeletal cancers, doctors have been successful in identifying certain patterns amongst people with these conditions. Genetic factors are most common and largely contribute to the development of musculoskeletal cancers, followed by factors such as – predisposition of Paget’s disease and undergoing radiation therapy.
In most cases, musculoskeletal cancers affect children in their teenage and women above the age of 30. And everyone above the age of 60 is equally at risk.
There are three major types of musculoskeletal cancers – osteosarcoma, chondrosarcoma and Ewing sarcoma. Osteosarcoma is the most common form and is largely evidenced in children. Chondrosarcoma is the second most common form of bone cancer and occurs primarily in the pelvis, legs or arms of middle-aged/elderly adults. Finally, Ewing sarcoma is the least common type of bone cancer largely affecting children & young adults.
The doctors employ a number of advanced screening methods to accurately diagnose musculoskeletal cancers. Primarily, a patient will be asked to undergo an X-ray, following which an MRI or a CT Scan will also be recommended. In most cases, a bone scan and PET are also commonplace. In some cases, a biopsy may be required for final confirmation of the cancer.
Treatment for musculoskeletal cancers is a multi-pronged approach and can involve any one or multiple combinations of surgery, radiation and chemotherapy. The doctors will arrive at the most viable treatment option for the patient based on the location of the cancer and its severity.
Yes, radio-frequency ablation is a minimally invasive procedure which is now being implemented for the treatment of musculoskeletal cancers. It is a form of radiation therapy, that is performed via the minimally invasive method.
The objective of a surgery for patients with musculoskeletal cancers is to remove the entire cancerous tumor and replacing the lost bone tissue with a graft.
The treatment modalities for musculoskeletal cancers have evidenced an excellent prognosis and a patient can expect to have a normal healthy lifestyle following the treatment. It is vital to have a comprehensive discussion on the expected outcomes with your surgeon prior to the surgery and understand the risks & complications involved, vis-à-vis the outcomes expected.
Epiphyseal lesions are usually giant cell tumors in adults or chondroblastoma’s in children. Many tumors are diaphyseal. Enchondromas and osteoid osteomas tend to be diaphyseal.
Osteoblastic tumors are predominantly sclerotic, which means the area affected by the lesions becomes rigid and unresponsive. Meanwhile, lytic tumors are often fibrous. And enchondromas & chondrosarcomas often have a mixed manifestation.
Intraosseous lesions include enchondromas and chondrosarcomas. Surface lesions include exostoses and periosteal osteosarcomas. Soft tissue lesions can invade bone.
Benign lesions tend to have well defined margins whereas aggressive lesions including metastatic disease have ill-defined margins.
Through our personalized treatment plan and integrated approach